NEW YORK, Nov. 12, 2010 (GLOBE NEWSWIRE) — The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today the results of the semi-annual re-ranking of the NASDAQ Biotechnology Index® (Nasdaq:NBI), which will become effective prior to market open on Monday, November 22, 2010.
The following five securities will be added to the Index: AVI BioPharma, Inc. (Nasdaq:AVII), Avanir [...] http://bit.ly/9EimUx
No comments:
Post a Comment